Masimo Corp. Company Profile (NASDAQ:MASI)

About Masimo Corp.

Masimo Corp. logoMasimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company's business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: MASI
  • CUSIP: 57479510
Key Metrics:
  • Previous Close: $58.58
  • 50 Day Moving Average: $58.86
  • 200 Day Moving Average: $50.54
  • 52-Week Range: $33.03 - $60.52
  • Trailing P/E Ratio: 30.72
  • Foreward P/E Ratio: 26.87
  • P/E Growth: 1.97
  • Market Cap: $2.89B
  • Outstanding Shares: 49,351,000
  • Beta: 0.8
  • Net Margins: 15.40%
  • Return on Equity: 29.07%
  • Return on Assets: 13.39%
  • Debt-to-Equity Ratio: 0.59%
  • Current Ratio: 2.46%
  • Quick Ratio: 1.94%
Additional Links:
Companies Related to Masimo Corp.:

Analyst Ratings

Consensus Ratings for Masimo Corp. (NASDAQ:MASI) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $53.00 (9.53% downside)

Analysts' Ratings History for Masimo Corp. (NASDAQ:MASI)
DateFirmActionRatingPrice TargetDetails
8/5/2016Piper Jaffray Cos.Reiterated RatingOverweight$52.00 -> $55.00View Rating Details
8/5/2016BTIG ResearchReiterated RatingHoldView Rating Details
8/4/2016WedbushReiterated RatingOutperform$60.00 -> $63.00View Rating Details
6/1/2016Raymond James Financial Inc.DowngradeStrong-Buy -> OutperformView Rating Details
5/5/2016Roth CapitalBoost Price TargetBuy$40.00 -> $50.00View Rating Details
1/9/2015Off Wall StreetReiterated RatingSellView Rating Details
(Data available from 9/30/2014 forward)


Earnings History for Masimo Corp. (NASDAQ:MASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2016Q216$0.41$0.57$166.02 million$172.64 millionViewListenView Earnings Details
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details
8/4/2015Q215$0.32$0.36$147.93 million$155.73 millionViewListenView Earnings Details
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details
8/7/2014Q214$0.29$0.24$145.76 million$140.92 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.30$144.01 million$139.80 millionViewListenView Earnings Details
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details
8/1/2012$0.28$0.27ViewN/AView Earnings Details
5/2/2012$0.28$0.27ViewN/AView Earnings Details
2/14/2012$0.23$0.23ViewN/AView Earnings Details
10/25/2011$0.27$0.24ViewN/AView Earnings Details
8/9/2011$0.28$0.28ViewN/AView Earnings Details
5/3/2011$0.30$0.30ViewN/AView Earnings Details
2/15/2011$0.26$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Masimo Corp. (NASDAQ:MASI)
Current Year EPS Consensus Estimate: $2.02 EPS
Next Year EPS Consensus Estimate: $2.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.40$0.43$0.42
Q2 20164$0.41$0.42$0.41
Q3 20164$0.41$0.43$0.42
Q4 20164$0.49$0.53$0.51
Q1 20171$0.54$0.54$0.54
Q2 20171$0.53$0.53$0.53
Q3 20171$0.50$0.50$0.50
Q4 20171$0.57$0.57$0.57
(Data provided by Zacks Investment Research)


Dividend History for Masimo Corp. (NASDAQ:MASI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Masimo Corp. (NASDAQ:MASI)
Insider Ownership Percentage: 16.60%
Institutional Ownership Percentage: 79.88%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/27/2016Joe E KianiCEOSell4,464$60.01$267,884.64View SEC Filing  
9/22/2016Joe E KianiCEOSell49,484$60.18$2,977,947.12View SEC Filing  
9/21/2016Sanford FitchDirectorSell2,000$59.41$118,820.00View SEC Filing  
9/20/2016Joe E KianiCEOSell400$60.16$24,064.00View SEC Filing  
9/19/2016Joe E KianiCEOSell999$60.03$59,969.97View SEC Filing  
9/7/2016Joe E KianiCEOSell33,536$60.00$2,012,160.00View SEC Filing  
9/7/2016Jon ColemanInsiderSell6,000$60.00$360,000.00View SEC Filing  
9/7/2016Sanford FitchDirectorSell2,000$59.81$119,620.00View SEC Filing  
8/17/2016Sanford FitchDirectorSell2,000$58.11$116,220.00View SEC Filing  
8/4/2016Jon ColemanInsiderSell22,000$56.82$1,250,040.00View SEC Filing  
8/4/2016Paul JansenEVPSell10,000$58.88$588,800.00View SEC Filing  
8/3/2016Sanford FitchDirectorSell2,000$52.62$105,240.00View SEC Filing  
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.00View SEC Filing  
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.00View SEC Filing  
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.00View SEC Filing  
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00View SEC Filing  
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68View SEC Filing  
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.00View SEC Filing  
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.00View SEC Filing  
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.00View SEC Filing  
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.00View SEC Filing  
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.00View SEC Filing  
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.00View SEC Filing  
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00View SEC Filing  
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00View SEC Filing  
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00View SEC Filing  
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.00View SEC Filing  
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.00View SEC Filing  
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00View SEC Filing  
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.00View SEC Filing  
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.00View SEC Filing  
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00View SEC Filing  
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.00View SEC Filing  
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.00View SEC Filing  
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Masimo Corp. (NASDAQ:MASI)
News IconBroker Roundup For Masimo Corporation (NASDAQ:MASI) (NASDAQ:MASI) - September 29 at 11:05 AM logoABIOMED Raised to Strong Buy: Should You Add the Stock? (NASDAQ:MASI) - September 29 at 11:05 AM logoStereotaxis secures $24 million in equity financing (NASDAQ:MASI) - September 27 at 5:57 PM logoMasimo Foundation Co-Finds the United for Oxygen Alliance (NASDAQ:MASI) - September 26 at 10:42 AM logoMasimo Foundation Co-Founds United for Oxygen Alliance (NASDAQ:MASI) - September 25 at 5:25 PM logoUptrend Call Working As Masimo Stock Rises 53.3% (MASI) (NASDAQ:MASI) - September 23 at 5:41 PM logoMasimo (MASI) Hits 52-Week High on Solid Growth Prospects - Nasdaq (NASDAQ:MASI) - September 21 at 5:45 PM logoMEDNAX (MD) Concludes Buyout of Anesthesiology Practices (NASDAQ:MASI) - September 21 at 10:09 AM logoMasimo Corporation (NASDAQ:MASI)’s Accounts Payable Is $30.71 (NASDAQ:MASI) - September 20 at 11:10 AM logoMasimo (MASI) Hits 52-Week High on Solid Growth Prospects (NASDAQ:MASI) - September 20 at 11:10 AM logoMasimo Corporation (NASDAQ:MASI)'s Accounts Payable Is $30.71 - (NASDAQ:MASI) - September 19 at 6:00 PM logoResearch Analysts Set Masimo Corporation (NASDAQ:MASI)’s Price Target At $59.2 (NASDAQ:MASI) - September 18 at 10:25 AM logoMasimo Corp. (MASI) Announces Publication of Positive Masimo ... - (NASDAQ:MASI) - September 15 at 4:02 PM logoMasimo Corp. (MASI) Announces Publication of Positive Masimo PVI Data (NASDAQ:MASI) - September 15 at 9:27 AM logoStudy on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVI® (NASDAQ:MASI) - September 15 at 9:27 AM logoMasimo Corporation (NASDAQ:MASI) Is Expected To Post EPS Of $0.52 (NASDAQ:MASI) - September 14 at 10:18 AM logoMasimo (MASI) Presents Encouraging SpHb Study Data (NASDAQ:MASI) - September 12 at 10:42 AM logoMasimo, Philips Argue For Quick Wins In Blood Sensor Fight (NASDAQ:MASI) - September 9 at 5:47 PM
News IconNew Study Finds Continuous, Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Intraoperative Red Blood Cell Tr... (NASDAQ:MASI) - September 9 at 5:47 PM logoMasimo Corp. (MASI) Announces Publication of Positive SpHb-Related Study Data (NASDAQ:MASI) - September 9 at 5:47 PM
News IconMasimo Corporation (NASDAQ: MASI) shares set new 52-week high - BNB Daily (blog) (NASDAQ:MASI) - September 9 at 10:46 AM logoMasimo Corp. (MASI) Announces Publication of Positive SpHb-Related Study Data - (NASDAQ:MASI) - September 9 at 10:46 AM logoNew Study Finds Continuous, Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Intraoperative Red Blood Cell Transfusion (NASDAQ:MASI) - September 9 at 10:46 AM logoMasimo to Present at Morgan Stanley Global Healthcare Conference (NASDAQ:MASI) - September 7 at 6:13 PM
News IconMasimo Personal Health (NASDAQ:MASI) - September 6 at 10:47 AM logoMasimo MightySat™ is Available at and Select Apple Retail Stores in the US and Canada (NASDAQ:MASI) - September 6 at 10:47 AM logoMasimo Amends Nellcor's Pulse Oximetry Royalty Agreement (NASDAQ:MASI) - September 6 at 10:47 AM
News IconGlobal Insights on Anesthesia Monitoring Devices Market Analysis, Size, Share, Growth, Trends And Segment Forecasts To 2024: Hexa Reports (NASDAQ:MASI) - September 5 at 5:27 PM logoA Price Target Of $59.2 Is Set By Research Analysts For Masimo Corporation (NASDAQ:MASI) (NASDAQ:MASI) - September 5 at 5:27 PM
News IconMasimo Hits 52-Week High: What's Backing The Stock? (NASDAQ:MASI) - September 5 at 5:27 PM logoPrice Target For Masimo Corporation (NASDAQ:MASI) Set At $59.2 ... - (NASDAQ:MASI) - September 4 at 10:16 AM logoBRIEF-Masimo announces amendment to settlement agreement between company and Nellcor (NASDAQ:MASI) - September 2 at 10:53 AM logoMASIMO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:MASI) - September 2 at 10:53 AM logoMasimo Announces Amendment to Nellcor Royalty Agreement (NASDAQ:MASI) - September 2 at 10:53 AM logoMasimo Reaches Analyst Target Price (NASDAQ:MASI) - August 30 at 6:04 PM
News IconMasimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists (WFSA) (NASDAQ:MASI) - August 30 at 9:22 AM logoAccounts Payable For Masimo Corporation (NASDAQ:MASI) Is $30.71 (NASDAQ:MASI) - August 30 at 9:22 AM logoBioTelemetry Gets CE Mark for Holter Monitoring Software (NASDAQ:MASI) - August 30 at 9:22 AM logoMasimo Announces a Special Worldwide Program for Total Hemoglobin (SpHb®) Monitoring for Areas Affected by the Zika Virus (NASDAQ:MASI) - August 29 at 5:57 PM logoMasimo Corporation (MASI) - Medical Equipment - Deals and Alliances Profile - New Market Research Report (NASDAQ:MASI) - August 26 at 9:03 AM logoMasimo Has Returned 49.7% Since SmarTrend Recommendation (MASI) (NASDAQ:MASI) - August 24 at 5:53 PM
News IconMapping the Clinton money stream (NASDAQ:MASI) - August 23 at 10:28 AM logoAnalysts Set $59.2 Price Target For Masimo Corporation (NASDAQ:MASI) (NASDAQ:MASI) - August 21 at 10:19 AM logoMasimo (MASI) Gets CE Mark for Respiration Sensor RAS-45 (NASDAQ:MASI) - August 19 at 9:03 AM logoMasimo Corp. (MASI) Receives CE Mark for RAS-45 (NASDAQ:MASI) - August 19 at 9:03 AM logo8:07 am Masimo announces the CE Marking of RAS-45, a single-use adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring of respiration rate (NASDAQ:MASI) - August 18 at 9:10 AM logoMasimo Announces CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring® of Respiration Rate (NASDAQ:MASI) - August 18 at 9:10 AM logoMasimo Up 50.4% Since SmarTrend Uptrend Call (MASI) (NASDAQ:MASI) - August 17 at 9:09 AM logoMasimo : New Article Showcases an Effective Surveillance System for General Care Units Using Masimo Patient SafetyNet™ (NASDAQ:MASI) - August 15 at 8:15 AM logoNew Article Showcases an Effective Surveillance System for General Care Units Using Masimo Patient SafetyNet™ (NASDAQ:MASI) - August 15 at 8:15 AM


Masimo Corp. (NASDAQ:MASI) Chart for Friday, September, 30, 2016

Last Updated on 9/30/2016 by Staff